Falsified Medicines Directive (FMD) implementation chief Jerome Bertin was unable to offer DDA 2017 conference delegates much reassurance about the progress towards practical implementation of the initiative.
In questions following his conference presentation, the general manager of the UK medicines verification organisation SecurMed could not tell dispensers when new FMD-compliant IT systems would be available, or when training would be provided ahead of the go-live date of Saturday 9 February, 2019. He also advised that as of 18 October 2017, NHS Services in devolved countries were not yet engaged.
However, among the assurances he was able to offer DDA delegates, he said that “NHS Digital …. is setting up a team to support GPs/health centres and would advise on when GP IT system providers will be engaged”. He added that a Department of Health/MHRA consultation was expected “later this year”.
In his update, he advised that changes will be needed to IT systems to enable medicines verification and to ways of working. He also reminded GPs that each stakeholder would be expected to pay for the costs of own installations.
He said he wanted to “raise awareness this is coming so impact can be assessed and change planned”. The DDA recognises the FMD as a current challenge to dispensing practice, and will support members throughout the implementation process.
Legislation for the delegated regulation designed to counter medicines fraud was issued in 2018 and, following the Brexit referendum vote, implementation has received on-going commitment from the Department of Health. In his presentation, Mr Bertin showed a picture of FMD-ready stock already in UK circulation.
According to SecurMed, in Operation Pangea (June 2015) the MHRA seized 6.2 million medicine doses/ medical devices worth £15.8m. Operation Pangea is an international week of action tackling the online sale of counterfeit and illicit medicines.
View the SecurMed conference presentation.